Skip to main content
CeloNova reaches financing deal with SWK, Congruent

A four-year financing deal was reached by CeloNova BioSciences with SWK Holdings and Congruent Investment Partners. The agreement is expected to provide CeloNova with capital for ongoing clinical trials, the release of its Cobra PzF NanoCoated coronary stent and other product initiatives.

Full Story: